How blood flow and sounds relate in arteriovenous fistulas
Official title: The Relationship Between Blood Flow Conditions and Sounds in Arteriovenous Fistulae for Hemodialysis
Run by Mario Negri Institute for Pharmacological Research · NCT06411353 · Data updated 2026-11-12
This study will test whether MRI and ultrasound recordings of blood flow and the sounds from an AVF can help predict fistula problems in adults with end-stage renal disease who need a new forearm access.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Mario Negri Institute for Pharmacological Research Academic / other |
| Locations | 1 site (Bergamo, Bergamo) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | February 2028 |
| Study ends | February 2028 |
| Registry record updated | September 4, 2025 |
| Trial ID | NCT06411353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–90 with end-stage renal disease who need a new autogenous forearm arteriovenous fistula and can undergo MRI and ultrasound are ideal candidates.
✕Probably not a fit
Patients with MRI contraindications, those already dialyzing via catheter or graft, those on peritoneal dialysis, individuals with a prior failed AVF in the same arm, or those with life expectancy under two years are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective non-pharmacological interventional study enrolling adults with end-stage renal disease who require creation of an autogenous forearm arteriovenous fistula. Participants will undergo non-contrast MRI and ultrasound (including a tUS Piur device) to generate patient-specific 3D AVF models and recordings of AVF sounds. Computational fluid dynamics will be used on the 3D models to characterize hemodynamic conditions such as oscillatory shear index and turbulent-like flow, which will be compared with recorded sounds and clinical outcomes. The goal is to determine whether noninvasive imaging and acoustics can predict sites at risk for stenosis or early AVF failure.
Why it matters
Potential benefit: If successful, this approach could enable earlier, noninvasive identification of AVFs at risk for stenosis or failure, allowing timely interventions to preserve vascular access.
How similar studies have gone: Previous CFD studies using MRI-derived AVF models have identified hemodynamic patterns linked to stenosis and early failure, and recent work suggests ultrasound-based 3D modeling is feasible, but combining sound analysis with CFD for prediction remains exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of informed consent prior to any study specific procedures. * Female and/or male aged between 18 and 90 years. * Patients in HD treatment who need a new VA or patients who entered the pre-dialysis program because of ESRD. In all cases, the first-choice treatment is the surgical creation of an autogenous AVF in patient's forearm. Exclusion Criteria: * Contraindications for the creation of an autogenous AVF. * Presence of a previously failed AVF in the same arm selected for surgery. * Patients with contraindications to MRI including: pregnancy, claustrophobia, cardiac pacemakers or other MRI-incompatible prostheses. * Patients already on HD treatment through a catheter or a graft. * Patients undergoing peritoneal dialysis. * Patients with a life expectancy of less than 2 years.
Where it's running
-
A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi
Bergamo, Bergamo, Italy Recruiting
Study contacts
- Principal investigator: Simona Zerbi, MD — ASST Papa Giovanni XXIII
- Study coordinator: Michela Bozzetto
- Email: michela.bozzetto@marionegri.it
- Phone: +3903545351
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ribupatide PK in People with Kidney Impairment
This study tests how a single shot of ribupatide behaves in the body for people with severe kidney problems compared to those with normal kidney function.
-
Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease
This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.
-
Pumpkin seed oil for people on hemodialysis
This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.
-
Porcine thymokidney transplant for end-stage renal disease
This study tests whether a GalKO porcine thymokidney transplant can keep kidney function without dialysis in adults with end-stage kidney disease who are unlikely to get a standard donor kidney soon.
-
How inflammatory diseases change the way your body handles medicines.
This study will see if inflammatory conditions like type 2 diabetes, IBD, or end-stage kidney disease change how common medicines are processed and increase the chance of side effects.
-
CRISPR-edited donor kidney transplant to reduce rejection risk
This trial will see if donor kidneys edited with CRISPR to turn off key HLA genes can lower rejection in adults with end-stage kidney disease receiving transplants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.